Zoltan Boda
Debrecen, HB, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease.
Journal: AJOG global reports
Published: June 19, 2025
Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Journal: International journal of molecular sciences
Published: February 09, 2024
Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells.
Journal: Stem cells international
Published: July 02, 2020
Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes.
Journal: International journal of molecular sciences
Published: October 25, 2019
A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: February 24, 2018
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants.
Journal: British journal of anaesthesia
Published: June 29, 2017
Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.
Journal: Thrombosis research
Published: December 28, 2016
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Journal: The Lancet. Haematology
Published: May 11, 2016
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
Journal: Thrombosis and haemostasis
Published: November 20, 2015
Last Updated: 09/26/2026